© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
HIV
HIV Mortality Rates Drop, But Minorities Impacted More
November 01, 2021
While HIV continues to impact certain racial and ethnic minorities, the mortality rate in the US continues to drop.
Top 3 HIV Treatment Findings from European AIDS Conference
November 01, 2021
Among the top studies presented at the 18th European AIDS Conference in London is the news that Gilead’s blockbuster HIV drug Biktarvy maintained virologic suppression after one year of treatment.
How Has the COVID-19 Pandemic Affected People With HIV?
October 04, 2021
A review of more than 200 studies found no greater risk of contracting COVID-19 among those with HIV but a greater chance of experiencing a severe case.
Researchers Outline How Gut Serves as Harbor for HIV, COVID-19
October 04, 2021
In a recent paper, researchers outlined the current understanding how the gut microbiome includes viruses such as HIV and COVID-19, and what it means for HIV treatment and repeat COVID-19 infection.
A Long-Acting PrEP Could Soon Be Available for HIV Prevention
October 03, 2021
The FDA is scheduled make a decision on injectable cabotegravir by Jan. 24, 2022.
Extended Study Follow-up Highlights Need for Improved Support for Engaging Those Who Inject Drugs Living With HIV in Treatment
September 05, 2021
The researchers suggest that additional support may be needed to ensure continuous and potentially increased use of antiretroviral treatment and medication for opioid use disorders and subsequent viral suppression.
One HIV Vaccine Fails While a First-of-its-Kind mRNA Vaccine Trial is Set to Begin
September 02, 2021
Johnson & Johnson’s experimental HIV vaccine, which uses the same technology as its COVID-19 vaccine, was found to not be effective at preventing infection.
First-of-its-Kind mRNA Vaccine Trial Reinvigorates Hope for Effective HIV Vaccine
September 01, 2021
Moderna's phase 1 trial of mRNA vaccine against HIV is deigned to enroll 40 patients.
Health Plan Leaders Can Step Up, Lead on PrEP Services
August 02, 2021
Amida Care’s Doug Wirth says they should work with state-level officials to make sure services are covered after Biden administration’s guidance that coverage is mandatory.
Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment
August 01, 2021
The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.